Cavan Appoints Matthew Harvey CEO of BC Bud Depot to Advisory Board

CAVAN VENTURES INC. (TSX VENTURE:CVN) ("Cavan" or the "Company") is pleased to
provide a corporate update in regards to the continuing exploration of the
potential of the Medical Marijuana and Hemp/Cannabinoid industry.


Cavan Ventures Inc. previously announced (see news release dated 2014-03-25) the
diversification of its growth plan into the Medical Marijuana and Hemp industry.
To accelerate this process, Matthew Harvey has joined the Company as its newest
member to the advisory board.


Mr. Harvey has been a master grower and in the industry since the mid 1990's
with world-wide exposure since 2004. Mr. Harvey is the Founder and CEO of BC Bud
Depot ("BCBD"), a producer of marijuana seeds. BCBD takes pride in developing
its award-winning THC and CBD cannabis strains. BCBD also collaborates with
other breeders and dispensaries (including Reeferman Seeds, T.H.Seeds and DNA
Genetics, and to European breeders like Soma Seeds and Delta-9 labs, and
California's The Honey Spot), and offers over 50 proprietary medicinal strains
to date with access to over 150 marijuana strains collaborated together with
associated partners. During Mr. Harvey's tenure, BCBD has received over 21
Cannabis Cup awards, including 7 first place awards, 9 Top Strain awards, 6 top
3 strain awards and an induction in 2009 to the Seed Bank Hall of Fame award.
Additionally, BC Bud Depot has outreach to over 11 North American dispensaries
and over 60 worldwide retail and web stores which stock BCBD'S products. Most
recently, Mr. Harvey has steered BCBD towards a new developmental approach to
medicinal genetics, producing unique strains to be used for specific medical
ailments.


Peter P. Swistak, President/CEO of Cavan Ventures Inc., states, "The depth and
scope of Mr. Harvey's knowledge is unparalleled and Cavan is very fortunate to
have access to this knowledge as we believe he is the best in his field with an
extensive bio and proven track record. He will add tremendous value, credibility
and unique knowledge to Cavan in its analysis of the Medical Marijuana and
Hemp/Cannabinoid industry, and potential opportunities in that industry. We are
excited to have Mr. Harvey available to us while we conduct due-diligence in the
Cannabinoid/Medicinal Marijuana space."


At this time, no transactions are in place, nor is there any assurance that a
new project will be concluded in the future.


For more information visit the website at www.cavanventuresinc.com.

ON BEHALF OF THE BOARD

Peter P. Swistak, President

Forward-Looking Statement: Certain statements in this release are
forward-looking statements, which reflect the expectations of management
regarding the Company's plans with respect to its existing graphite interests,
future financings, and the analysis and investigation of the medical marijuana
sphere. Forward-looking statements consist of statements that are not purely
historical, including any statements regarding beliefs, plans, expectations or
intentions regarding the future and statements concerning the anticipated
drilling programs, future financings, and the Company proceeding with any
transactions in the medical marijuana sphere. Such statements are subject to
risks and uncertainties that may cause actual results, performance or
developments to differ materially from those contained in the statements. No
assurance can be given that any of the events anticipated by the forward-looking
statements will occur or, if they do occur, what benefits the Company will
obtain from them. In particular, the Company cautions that any financings or
potential transactions cannot be predicted with certainty, and there can be no
assurance at this time that all required or desirable approvals and consents to
affect future financings or proposed transactions will be achieved at all. These
forward-looking statements reflect management's current views and are based on
certain expectations and assumptions which may prove to be incorrect. A number
of risks and uncertainties could cause our actual results to differ materially
from those expressed or implied by the forward-looking statements, including
factors beyond the Company's control. These forward-looking statements are made
as of the date of this news release.


Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Cavan Ventures Inc.
604-683-3995
888-945-4770
604-683-3988 (FAX)
www.cavanventuresinc.com